These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19121146

  • 1. Calcineurin inhibitor minimization protocols in liver transplantation.
    Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ.
    Transpl Int; 2009 Jan; 22(1):49-60. PubMed ID: 19121146
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM, Kobashigawa J, Klintmalm G.
    Clin Transplant; 2008 Jan; 22(1):1-15. PubMed ID: 18217899
    [Abstract] [Full Text] [Related]

  • 4. Calcineurin-inhibitor-sparing immunosuppressive protocols.
    Bestard O, Cruzado JM, Grinyó JM.
    Transplant Proc; 2005 Nov; 37(9):3729-32. PubMed ID: 16386520
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation.
    Créput C, Blandin F, Deroure B, Roche B, Saliba F, Charpentier B, Samuel D, Durrbach A.
    Liver Transpl; 2007 Jul; 13(7):1004-10. PubMed ID: 17600361
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Calcineurin inhibitor withdrawal and conversion to mycophenolate mofetil and steroids in cardiac transplant recipients with chronic renal failure: a word of caution.
    Groetzner J, Kaczmarek I, Schirmer J, Uberfuhr P, Gulbins H, Daebritz S, Meiser B, Reichart B.
    Clin Transplant; 2008 Jul; 22(5):587-93. PubMed ID: 18460000
    [Abstract] [Full Text] [Related]

  • 9. Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors?
    Beckebaum S, Cicinnati VR, Radtke A, Kabar I.
    Liver Int; 2013 May; 33(5):656-65. PubMed ID: 23442173
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
    Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M.
    Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
    [Abstract] [Full Text] [Related]

  • 13. Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.
    Penninga L, Wettergren A, Chan AW, Steinbrüchel DA, Gluud C.
    Cochrane Database Syst Rev; 2012 Mar 14; 2012(3):CD008852. PubMed ID: 22419339
    [Abstract] [Full Text] [Related]

  • 14. Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients.
    Mourer JS, de Koning EJ, van Zwet EW, Mallat MJ, Rabelink TJ, de Fijter JW.
    Transplantation; 2013 Jul 15; 96(1):49-57. PubMed ID: 23715049
    [Abstract] [Full Text] [Related]

  • 15. Calcineurin-inhibitor minimization protocols in heart transplantation.
    Zuckermann AO, Aliabadi AZ.
    Transpl Int; 2009 Jan 15; 22(1):78-89. PubMed ID: 18954366
    [Abstract] [Full Text] [Related]

  • 16. Calcineurin inhibitor sparing in renal transplantation.
    Ekberg H.
    Transplantation; 2008 Sep 27; 86(6):761-7. PubMed ID: 18813097
    [Abstract] [Full Text] [Related]

  • 17. Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation.
    Kamar N, Del Bello A, Belliere J, Rostaing L.
    Transpl Int; 2015 Aug 27; 28(8):928-37. PubMed ID: 25557802
    [Abstract] [Full Text] [Related]

  • 18. Calcineurin inhibitor minimization, withdrawal and avoidance protocols after kidney transplantation.
    Haller M, Oberbauer R.
    Transpl Int; 2009 Jan 27; 22(1):69-77. PubMed ID: 18764837
    [Abstract] [Full Text] [Related]

  • 19. Improvement of renal function after conversion to mycophenolate mofetil combined with low-level calcineurin inhibitor in liver transplant recipients with chronic renal dysfunction.
    Ponton C, Vizcaíno L, Tomé S, Otero E, Molina E, Castroagudín JF, López-Lago A, Varo Pérez E.
    Transplant Proc; 2010 Mar 27; 42(2):656-9. PubMed ID: 20304216
    [Abstract] [Full Text] [Related]

  • 20. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients.
    Groetzner J, Kaczmarek I, Landwehr P, Mueller M, Daebritz S, Lamm P, Meiser B, Reichart B.
    Eur J Cardiothorac Surg; 2004 Mar 27; 25(3):333-41. PubMed ID: 15019657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.